Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Bio-Works Technologies

1,825

 

SEK

 

-1,88 %

Mindre end 1K følgere

BIOWKS

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus
Sammenligne
-1,88%
+42,02%
+24,73%
+89,51%
+99,78%
+16,38%
-85,78%
-64,83%
-78,76%

Bio-Works Technologies is a biotechnology company. The company develops products that separate and purify molecules in the production of drugs. The technology is based on chromatography that aims to handle the drug substance. Customers are found in the European market where products are sold through distribution partners and to companies in the pharmaceutical industry. They are also sold to research institutes and universities. The company was founded in 2006 and is headquartered in Uppsala.

Læs mere
Markedsværdi
143,69 mio. SEK
Aktieomsætning
21,85 t SEK
Omsætning
25,47 mio.
EBIT %
-149,2 %
P/E
-
Udbytteafkast, %
-
Finanskalender
22.8
2025

Delårsrapport Q2'25

20.2
2026

Årsrapport '25

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse16.5.2025, 13.09

Bio-Works Technologies AB: Correction to press release sent our yesterday

Bio-Works Technologies
Selskabsmeddelelse15.5.2025, 13.02

Bio-Works Technologies AB: Bio-Works receives WorkBeads order worth SEK 2.5 million

Bio-Works Technologies
Selskabsmeddelelse15.5.2025, 08.30

Bio-Works Technologies AB: Resolutions passed at Bio-Works Technologies' annual general meeting 2025

Bio-Works Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Selskabsmeddelelse15.5.2025, 05.00

Bio-Works Technologies AB: Bio-Works reports first quarter 2025

Bio-Works Technologies
Selskabsmeddelelse29.4.2025, 14.04

Bio-Works Technologies AB: Bio-Works Receives Order Worth SEK 2.4 Million from New European Customer in Vaccine Production

Bio-Works Technologies
Selskabsmeddelelse15.4.2025, 15.00

Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 2 of 11

Bio-Works Technologies
Selskabsmeddelelse14.4.2025, 14.27

Bio-Works Technologies AB: Bio-Works receives SEK 12 million order from global pharmaceutical company - delivery scheduled for 2026

Bio-Works Technologies
Selskabsmeddelelse1.4.2025, 06.00

Today is the first day of the second exercise period for Bio-Works Technologies AB's warrants of series TO 2

Bio-Works Technologies
Selskabsmeddelelse27.3.2025, 15.02

Bio-Works Technologies AB: Bio-Works Receives New Orders for Custom GoBio Columns for the U.S. Gene Therapy Market

Bio-Works Technologies
Selskabsmeddelelse26.2.2025, 13.49

Bio-Works Technologies AB: Bio-Works Receives Order for WorkBeads Worth 2.65 Million SEK

Bio-Works Technologies
Selskabsmeddelelse21.2.2025, 07.00

Bio-Works Technologies AB: Bio-Works publishes year-end report Q4 2024

Bio-Works Technologies
Pressemeddelelse14.2.2025, 11.46

Bio-Works Technologies AB: Bio-Works Technologies Doubles Production Capacity to Meet Growing Demand

Bio-Works Technologies
Selskabsmeddelelse10.2.2025, 10.54

Bio-Works Technologies AB: Bio-Works receives a third follow-up order for WorkBeads affimAb worth SEK 4.0 million

Bio-Works Technologies
Selskabsmeddelelse31.1.2025, 12.24

Bio-Works Technologies AB: Bio-Works Receives Follow-Up Order for WorkBeads affimAb Worth 4.6 MSEK

Bio-Works Technologies
Selskabsmeddelelse14.1.2025, 12.33

Bio-Works Technologies AB: Bio-Works Confirms a New Order for WorkBeads affimAb for Use in Antibody Production for 11.2 MSEK

Bio-Works Technologies
Selskabsmeddelelse2.1.2025, 10.39

The first day to exercise Bio-Works Technologies AB's warrants of series TO 2 is today

Bio-Works Technologies
Selskabsmeddelelse12.11.2024, 17.21

Bio-Works Technologies AB: Letter of Intent for order of WorkBreads affimAb increased to 11,9 Mkr

Bio-Works Technologies
Selskabsmeddelelse6.11.2024, 06.50

Bio-Works publishes Q3 report 2024

Bio-Works Technologies
Pressemeddelelse4.11.2024, 15.30

Bio-Works comfirms an order from Nemysis Ltd worth 2.2 MSEK

Bio-Works Technologies
Selskabsmeddelelse4.11.2024, 08.50

Bio-Works receives a Letter of Intent (LOI) - the anticipated order value is €652,000.

Bio-Works Technologies
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team